Results 221 to 230 of about 125,774 (256)

MINOXIDIL IN RESISTANT HYPERTENSION

The Lancet, 1977
Minoxidil in combination with propranolol and diuretics controlled the blood-pressure in a group of hypertensive patients who were resistant to treatment with large doses of standard drugs. The main problem was fluid retention but subjective side-effects were fewer than in a comparable group on other drugs.
H J, Dargie, C T, Dollery, J, Daniel
openaire   +4 more sources

Insulin resistance and hypertension

Molecular and Cellular Endocrinology, 1990
Diminished insulin (Ins) sensitivity is a characteristic feature of various pathological conditions such as the cardiometabolic syndrome, Type 2 diabetes, and hypertension. Persons with essential hypertension are more prone than normotensive persons to develop diabetes, and this propensity may reflect decreased ability of Ins to promote relaxation and
openaire   +5 more sources

Resistant hypertension, secondary hypertension, and hypertensive crises

Cardiology Clinics, 2002
Resistant hypertension, secondary hypertension, and hypertensive crises are uncommon but potentially dangerous forms of hypertension that are associated with an increased risk of complications such as myocardial infarction, heart failure, stroke, and renal failure.
openaire   +2 more sources

Labetalol in resistant hypertension

Acta Medica Scandinavica, 1982
ABSTRACT. In 12 patients with resistant hypertension labetalol was added to existing therapy. The average dose was 1333 mg (range 400–3600). The subjects were followed up for three and a half years. Mean supine blood pressure (BP) was reduced from 202/123 to 163/103 mm Hg and mean standing BP from 193/127 to 144/100 mm Hg.
openaire   +2 more sources

Hypertension and Insulin Resistance

Journal of Cardiovascular Pharmacology, 1992
Insulin resistance and hyperinsulinemia is now recognized in non-insulin-dependent diabetes, essential hypertension, obesity, atherosclerotic heart disease, dyslipidemia, heart failure, and in heavy smokers. Several mechanisms have been proposed to explain hyperinsulinemia, insulin resistance and its relationship to hypertension; reduced sodium ...
B N, Prichard, C C, Smith, S, Sen, D J, Betteridge   +3 more
openaire   +2 more sources

Resistant hypertension in 2017

Current Opinion in Cardiology, 2017
Hypertension (HTN) is a ubiquitous condition and cause for significant morbidity and mortality. Over 400 000 deaths in the United States are related to HTN every year, more than all the Americans who died through all of World War II. As many as half the patients with HTN in the United States have resistant HTN, a blood pressure greater than 140/90 mmHg
Hans, Sartaj, Reilly, John P.
openaire   +4 more sources

Treatment of Resistant Hypertension

2018
Hypertension cannot always be controlled by the classical antihypertensive treatment strategies whose therapeutic failure leads to a condition known as resistant hypertension [1]. This chapter will discuss the prevalence within a hypertensive state of individuals in whom blood pressure (BP) remains uncontrolled despite appropriate treatment.
Seravalle, G, Grassi, G, Mancia, G
openaire   +1 more source

Treatment of resistant hypertension

Current Hypertension Reports, 2005
Although the true prevalence of resistant hypertension is not known, it is likely that this condition will become increasingly common, driven by an aging population, obesity, nonadherence trends, and effects of target-organ disease. Current approaches focus on two goals: evaluation and correction of contributing causes, then selection of an effective ...
openaire   +2 more sources

Definitions of Resistant Hypertension and Epidemiology of Resistant Hypertension

2017
Hypertension remains one of the most preventable causes of premature, especially cardiovascular and renal, morbidity and mortality. Antihypertensive trials consistently demonstrate a significant health benefit from lowering blood pressure. Most hypertension can be controlled with lifestyle changes and antihypertensive agents.
openaire   +1 more source

Treatment Resistant Hypertension

American Journal of Therapeutics, 2008
Treatment resistant hypertension is defined as a blood pressure not achieving a goal blood pressure (
openaire   +2 more sources